New York Times article describing how Gene Drive (i.e., a soon-to-be-mainstreamed term that includes CRISPR gene-altering capabilities) is being addressed from a governing policy perspective. To some degree, this is an encouraging piece that conveys an important set of discourse is underway proactively rather than well after the cat has been let out of the bag.

Link to article.